Maritza D. Diego BS., PA-C, MMS.
Chief Executive Officer
FXM Clinical Research Miami, LLC / Hector Wiltz, M.D., C.P.I.
11760 Bird Road, Suite 452
Miami, FL 33175
(305) 675-3152 (fax)
Currently Enrolling Trials
FXM Research is a privately owned and operated Clinical Research Site that conducts phase I, II, III, and IV clinical research trials specializing in Dermatology. Throughout the years, our ability to deliver aggressive, time bound enrollment goals, while providing trustworthy data to Pharmaceutical companies and CROs, has earned FXM Research a great deal of notoriety and fame within the Dermatology research industry.
Today, FXM Research’s success is widely regarded throughout our four operating branches: FXM Clinical Research Miami, LLC., based in Miami, Florida and home of our headquarters, FXM Clinical Research Miramar, LLC, located in the city of Miramar, Florida, FXM Clinical Research Ft. Lauderdale, located in Fort Lauderdale, Florida, FXM Research International, including two branches in Belize City, Central America, and one in St. Lucia, Caribbean.
At the core of our business and operating systems, FXM Research mission is to support pharmaceutical companies and CROs with introducing new and approved FDA medications successfully into the marketplace. We perform this efficiently and effectively by providing the highest quality service in a timely fashion and at the lowest possible cost.
- Our primary concerns are subject safety and adherence to the protocol.
- Turnover time for Regulatory Documents, budgets, and contracts is usually 24 to 48 hours.
- We offer experienced, trained, and bilingual personnel (English and Spanish), who interact with our subjects, sponsors, and CROs as a cohesive team.
- Our Principal Investigators are Board Certified Dermatologists and Certified Clinical Research Investigators with many years of extensive experience. They are located on-site and are available full-time.
- Our Principal Investigators evaluate each and every study subject.
- Most subjects are recruited through advertising and/or FXM Research's extensive clinical database. We draw heavily from a Spanish speaking population, a group often under-represented in clinical trials.
- We also have continuing extensive experience with a pediatric population.
- We do whatever is necessary to accommodate our subjects' school and/or work schedule, which maximizes compliance and retention.
Since the year 2000, FXM Research group of companies have been involved with more than 70 of the most respected pharmaceutical companies and organizations in the world known as sponsors; conducting over 450 Clinical Trials cumulatively in Dermatology.
We have acted as a clinical research site in numerous dermatological studies where our normal enrollment consists of well over 40 subjects with almost 99% compliance from such subjects
The following are the main therapeutic conditions in dermatology that FXM Research group has conducted studies of:
- TINEA PEDIS
- ACTINIC KERATOSIS
- ATOPIC DERMATITIS
- LICHEN SIMPLEX CRONICUS
- SEBORRHOEIC DERMATITIS
- SECONDARILY INFECTED LESIONS
- SOLAR LENTIGINES
- TINEA CAPITIS
- TINEA CORPORIS
- TINEA CRURIS
- ICHTHYOSIS VULGARIS
Our principal investigator, Hector Wiltz, M.D., C.P.I., is on site full time. This is because our office houses both; our research site and Dr. Wiltz’ private practice.
Our site includes a designated research area with private examining rooms to provide confidentiality and comfort for our subjects. Furthermore, our facility also includes a secured area for studied medications, case report forms and record storage. A private office is also available to ensure comfortable, peaceful and undistracted monitoring visits for our CRA’s.
Our clinical research center is located inside the Kendall Medical Center, which is on the corner of Bird Road (SW 40th Street) and 117th Avenue with the Florida Turnpike running parallel to the center. The Florida Turnpike South can be accessed from either I-95, I- 595, I -75 or the 836 West. The center can also be accessed from the Palmetto Expressway (826 North or South) by exiting on Bird Road and heading West just past 117th avenue.
Principal Investigator / FXM Clinical Research Miami, LLC
Dr. Hector Wiltz, M.D., C.P.I. is a Board Certified Dermatologist with over 35 years of extensive experience in the field of Dermatology.
As of late, Dr. Wiltz has conducted over 218 Clinical Research trials serving as the Principal Investigator for FXM Research in Miami; FL. Dr. Wiltz has attended a GCP seminar, sponsored by ACRP, and completed Investigator Training for Medical Research.
He is certified as a C.P.I. and is an active member of Alpha Omega Alpha National Honor Medical Society, the American Academy of Dermatology and the Florida Medical Association.
Hector Wiltz, M.D., C.P.I.
Dr. Wiltz is a board certified Dermatologist with over 34 years of extensive experience. Furthermore, Dr. Wiltz has acted as Principal Investigator on over 208 successful Clinical Research trials.
Francisco Moncada, R.N., B.S.N., C.C.R.C.
Mr. Moncada is the Founder of FXM Research. Francisco Moncada has worked with Dr. Wiltz for over 27 years and has extensive experience in most dermatological conditions and disorders. In the year 2000, Mr. Moncada founded his first clinical research site FXM Research with operations in Miami, FL. Today, the site in Miami has conducted over 218 Clinical trials in dermatology under the Direction/Management of Mr. Moncada & Mrs. Diego.
In late 2006, after many years of achieving outstanding results conducting clinical trials, Mr. Moncada widened his prospective to the international arena by founding FXM Research International which today, consists of two solid and experienced research sites in dermatology located in Belize City, Central America. Together, these sites have successfully conducted over 100 studies. FXM International has continued to organically expand with the addition of St. Lucia, Caribbean.
To further widen the scope of opportunities FXM Research has to offer to Pharmaceuticals and CRO Sponsors in the United States, FXM Research Miramar, with operations in the city of Miramar, FL; was founded in late 2008. The sites is proud to have conducted over 141 studies in Dermatology.
Maritza D. Diego, BS., PA-C, MMS.
Chief Operating Officer
Mrs. Diego began her Clinical Research career at FXM in 2007. Her determination and excellence working successfully in every position within the company has demonstrated her superior understanding for Good Clinical Practice. Her ability to leverage her educational background and extensive experience in Clinical Research has exacerbated her knowledge and complete understanding on how to direct/guide any clinical research study.
As the CEO, Mrs. Diego job is to handle all Regulatory aspects involved in the trials, oversee the success and achievement of all personnel assisting in the trials, and supervise subject’s conduct during the trial. Mrs. Diego’s management directive is to ensure FXM Clinical Research Miami, FXM Clinical Research Miramar, LLC & FXM Clinical Research Ft. Lauderdale, LLC sites convey the same unequivocal quality of standards for each and every study. Mrs. Diego is certified in HIV/OSHA, CPR,GCP AND IATA regulations.
We are always ranked among the highest enrolling sites in trials we participate in. This is because of our extensive patient/subject database. Our patient/subject database consists of FXM’s own extensive clinical research database. Our patient/subject target population consists of the following and includes males and females of all age groups:
16% African American
Our subjects give us several reasons why they decide to participate in our Clinical Research studies. The ones they most often mention are:
- To help in the development of new medications that may offer better treatment or even
cures for chronic diseases.
- The availability of diagnostic tests and medical evaluation of a particular disease or medical condition without worrying about the cost.
- The Hope for a new approach or treatment that finally offers some relief. For all subjects' database management, we comply with privacy and confidentiality of all HIPAA regulations.
For all regulatory issues, we adhere to the assigned Central Institutional Review Board.